Understanding cell culture dynamics: a tool for defining protocol parameters for improved processes and efficient manufacturing using human embryonic stem cells

References

• Cell IS. Therapies for Parkinson’s Disease. Clin Transl Sci. 2019;12(2):95–97.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. Guideline on human cell-based medicinal products. EMA. 2008;EMA: EMEA/CHMP/410869/2006.
   Google Scholar
• Deasy BM, Jankowski RJ, Payne TR, et al. Modeling stem cell population growth: incorporating terms for proliferative heterogeneity. Stem Cells. 2003;21(5):536–545.
   PubMed Web of Science ®Google Scholar
• Bravery CA, Carmen J, Fong T, et al. Potency assay development for cellular therapy products: an ISCT* review of the requirements and experiences in the industry. Cytotherapy. 2013;15(9–19):e9.
   PubMedGoogle Scholar
• Kusena JW, Thomas RJ, McCall MJ, et al. From protocol to product: ventral midbrain dopaminergic neuron differentiation for the treatment of Parkinson’s disease. Regen Med. 2019;14(11):1057–1069.
   PubMed Web of Science ®Google Scholar
• Skottman H, Mikkola M, Lundin K, et al. Gene expression signatures of seven individual human embryonic stem cell lines. Stem Cells. 2005;23(9):1343–1356.
   PubMed Web of Science ®Google Scholar
• Allegrucci C, Denning CN, Burridge P, et al. Human embryonic stem cells as a model for nutritional programming: an evaluation. Reprod Toxicol. 2005;20(3):353–367.
   PubMed Web of Science ®Google Scholar
• Herberts CA, Kwa MSG, Hermsen HPH. Risk factors in the development of stem cell therapy. J Transl Med. 2011;9(1):1–14.
   Google Scholar
• Brandao KO, Tabel VA, Atsma DE, et al. Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies. DMM Dis Model Mech. 2017;10(9):1039–1059.
   PubMed Web of Science ®Google Scholar
• Mountford JC. Human embryonic stem cells: origins, characteristics and potential for regenerative therapy. Transfus Med. 2008;18(1):1–12.
   PubMed Web of Science ®Google Scholar
• Volarevic V, Markovic BS, Gazdic M, et al. Ethical and Safety Issues of Stem Cell-Based Therapy. Int J Med Sci. 2018;15(1):36–45.
   PubMed Web of Science ®Google Scholar
• Merkle FT, Eggan K. Modeling human disease with pluripotent stem cells: from genome association to function. Cell Stem Cell. 2013;12(6):656–668.
   PubMed Web of Science ®Google Scholar
• National Institutes of Health. Stem cell basics VII. [Internet]. Stem Cell Inf 2016 [cited 2021 Jan 11]; Available from: https://stemcells.nih.gov/info/basics/7.htm
   Google Scholar
• BlueRock Therapeutics. Pipeline - Engineered Cell Therapy [Internet]. 2019; Available from: https://bluerocktx.com/pipeline/
   Google Scholar
• Studer L Strategies for bringing stem cell-derived dopamine neurons to the clinic—The NYSTEM trial. In: Progress in Brain Research. 2017. 191–212.
   Google Scholar
• Nolbrant S, Heuer A, Parmar M, et al. Generation of high-purity human ventral midbrain dopaminergic progenitors for in vitro maturation and intracerebral transplantation. Nat Protoc. 2017;12(9):1962–1979.
   PubMed Web of Science ®Google Scholar
• Kirkeby A, Nolbrant S, Tiklova K, et al. Predictive markers guide differentiation to improve graft outcome in clinical translation of hESC-based therapy for Parkinson’s Disease. Cell Stem Cell. 2017;20(1):135–148. .
   PubMed Web of Science ®Google Scholar
• Grealish S, Diguet E, Kirkeby A, et al. Human ESC-derived dopamine neurons show similar preclinical efficacy and potency to fetal neurons when grafted in a rat model of Parkinson’s disease. Cell Stem Cell. 2014;15(5):653–665. .
   PubMed Web of Science ®Google Scholar
• ISO International Organization for Standardization. ISO 9001:2015 - Quality management systems—requirements [Internet]. 2015 [cited 2020 Dec 16]. Available from: https://www.iso.org/standard/62085.html
   Google Scholar
• Li MD, Atkins H, Bubela T. The global landscape of stem cell clinical trials. Regen Med. 2014;9(1):27–39.
   PubMed Web of Science ®Google Scholar
• Bubela T, McCabe C, Archibald P, et al. Bringing regenerative medicines to the clinic: the future for regulation and reimbursement. Regen Med. 2015;10(7):897–911. .
   PubMed Web of Science ®Google Scholar
• Stoker TB, Barker RA. Cell therapies for Parkinson’s disease: how far have we come? Regen Med. 2016;11(8):777–786.
   PubMed Web of Science ®Google Scholar
• Yasuhara T, Kameda M, Sasaki T, et al. Cell Therapy for Parkinson’s Disease. Cell Transplant. 2017;26(9):1551–1559.
   PubMed Web of Science ®Google Scholar
• Trounson A, McDonald C. Stem Cell Therapies in Clinical Trials: progress and Challenges. Cell Stem Cell. 2015;17(1):11–22.
   PubMed Web of Science ®Google Scholar
• Heathman TRJ, Nienow W, Mccall MJ, et al. The translation of cell-based therapies : clinical landscape and manufacturing challenges. Regen Med. 2015;10(1):49–64.
   PubMed Web of Science ®Google Scholar
• Shariatzadeh M, Chandra A, Wilson SL, et al. Distributed automated manufacturing of pluripotent stem cell products. Int J Adv Manuf Technol. 2020;106(3–4):1085–1103. .
   PubMed Web of Science ®Google Scholar
• Phelan K, May KM. Basic techniques in mammalian cell tissue culture. Curr Protoc Toxicol. 2016;70(1):A.3B.1-A.3B.22.
   PubMedGoogle Scholar
• Kusena JWT, Shariatzadeh M, Studd AJ, et al. The importance of cell culture parameter standardization: an assessment of the robustness of the 2102Ep reference cell line. Bioengineered. 2020;21:341–357.
   Google Scholar
• Lipsitz YY, Timmins NE, Zandstra PW. Quality cell therapy manufacturing by design. Nat Biotechnol. 2016;34(4):393–400.
   PubMed Web of Science ®Google Scholar
• Williams DJ, Archer R, Archibald P, et al. Comparability: manufacturing, characterization and controls, report of a UK regenerative medicine platform pluripotent stem cell platform workshop, Trinity Hall, Cambridge, 14-15 September 2015. Regen Med. 2016;11(5):483–492. .
   PubMed Web of Science ®Google Scholar
• Mount NM, Ward SJ, Kefalas P, et al. Cell-based therapy technology classifications and translational challenges. Philos Trans R Soc B Biol Sci. 2015;370(1680):1–16.
   Web of Science ®Google Scholar
• Chiou S-H, Yu -C-C, Huang C-Y, et al. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res. 2008;14(13):4085–4095.
   PubMed Web of Science ®Google Scholar
• Adewumi O, Aflatoonian B, Ahrlund-Richter L, et al. Characterization of human embryonic stem cell lines by the international stem cell initiative. Nat Biotechnol. 2007;25:803–816.
   PubMed Web of Science ®Google Scholar
• Osumi N, Shinohara H, Numayama-Tsuruta K, et al. Concise Review: pax6 transcription factor contributes to both embryonic and adult neurogenesis as a multifunctional regulator. Stem Cells. 2008;26(7):1663–1672.
   PubMed Web of Science ®Google Scholar
• Zetterström Axell M, Zlateva S, Curtis M. A method for rapid derivation and propagation of neural progenitors from human embryonic stem cells. J Neurosci Methods. 2009;184(2):275–284.
   PubMed Web of Science ®Google Scholar
• Tomishima M. Neural induction – Dual SMAD inhibition. StemBook [Internet]. 2014. 18:1–5. Available from:. http://www.stembook.org/node/727
   Google Scholar
• Politis SN, Colombo P, Colombo G, et al. Design of experiments (DoE) in pharmaceutical development. Drug Dev Ind Pharm. 2017;43(6):889–901.
   PubMed Web of Science ®Google Scholar
• Yu LX, Amidon G, Khan MA, et al. Understanding pharmaceutical quality by design. Aaps J. 2014;16(4):771–783.
   PubMed Web of Science ®Google Scholar
• Josephson R, Ording CJ, Liu Y, et al. Qualification of Embryonal Carcinoma 2102Ep As a reference for human embryonic stem cell research. Stem Cells. 2007;25(2):437–446. .
   PubMed Web of Science ®Google Scholar
• Andrews PW. Human embryonal carcinoma cells in culture do not synthesize fibronectin until they differentiate. Int J Cancer. 1982;30(5):567–571.
   PubMed Web of Science ®Google Scholar
• Pamies D. Good Cell Culture Practice for stem cells and stem-cell-derived models. ALTEX [Internet]. 2016. 34:95–132. Available from:. http://www.altex.org/index.php/altex/article/view/76
   PubMedGoogle Scholar
• Allegrucci C, Young LE. Differences between human embryonic stem cell lines. Hum Reprod Update. 2007;13(2):103–120.
   PubMed Web of Science ®Google Scholar
• Geraghty RJ, Capes-Davis A, Davis JM, et al. Guidelines for the use of cell lines in biomedical research. Br J Cancer. 2014;111(6):1021–1046. .
   PubMed Web of Science ®Google Scholar
• Plaia TW, Josephson R, Liu Y, et al. Characterization of a new NIH-Registered variant human embryonic stem cell line, BG01V: a tool for human embryonic stem cell research. Stem Cells. 2006;24(3):531–546. .
   PubMed Web of Science ®Google Scholar
• Freshney RI. Culture of Animal Cells [Internet]. Hoboken, NJ, USA: John Wiley & Sons, Inc. 2010. Available from: http://doi.org/10.1002/9780470649367
   Google Scholar
• Phelan MC. Techniques for mammalian cell tissue culture. Curr Protoc Hum Genet. 2006;Appendix 3:A.3F.1-A.3F.18.
   PubMedGoogle Scholar
• Marin V, Kaplanski G, Grès S, et al. Endothelial cell culture: protocol to obtain and cultivate human umbilical endothelial cells. J Immunol Methods. 2001;254(1–2):183–190.
   PubMed Web of Science ®Google Scholar
• Soleimani M, Nadri S. A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. Nat Protoc. 2009;4(1):102–106.
   PubMed Web of Science ®Google Scholar
• Kirkeby A, Parmar M, Barker RA Strategies for bringing stem cell-derived dopamine neurons to the clinic: a European approach (STEM-PD). Prog Brain Res. 2017;230:165–190.
   Google Scholar
• Mehrabani D, Mahdiyar P, Torabi K, et al. Growth kinetics and characterization of human dental pulp stem cells: comparison between third molar and first premolar teeth. J Clin Exp Dent. 2017;9(2):e172–7.
   PubMedGoogle Scholar
• Yuan L, Liu HQ, Wu MJ. Human embryonic mesenchymal stem cells participate in differentiation of renal tubular cells in newborn mice. Exp Ther Med. 2016;12(2):641–648.
   PubMed Web of Science ®Google Scholar
• Jung S, Panchalingam KM, Rosenberg L, et al. Ex vivo expansion of human mesenchymal stem cells in defined serum-free media. Stem Cells Int. 2012;2012:1–21.
   Web of Science ®Google Scholar
• Carmen J, Burger SR, McCaman M, et al. Developing assays to address identity, potency, purity and safety: cell characterization in cell therapy process development. Regen Med. 2012;7(1):85–100.
   PubMed Web of Science ®Google Scholar
• Huang J, Kaul G, Cai C, et al. Quality by design case study: an integrated multivariate approach to drug product and process development. Int J Pharm. 2009;382(1–2):23–32.
   PubMed Web of Science ®Google Scholar
• French A, Bravery C, Smith J, et al. Enabling consistency in pluripotent stem Cell-Derived products for research and development and clinical applications through material standards. Stem Cells Transl Med. 2015;4(3):217–223. .
   PubMed Web of Science ®Google Scholar
• Barker RA, Parmar M, Studer L, et al. Human trials of stem cell-derived dopamine neurons for Parkinson’s Disease: dawn of a new era. Cell Stem Cell. 2017;21(5):569–573.
   PubMed Web of Science ®Google Scholar
• Thompson M, Thompson M, Nemits M, et al. Rate‐controlled Cryopreservation and Thawing of Mammalian Cells [Internet]. Protoc Exch. 2011. Available from:. http://www.nature.com/protocolexchange/protocols/208510.1038/protex.2011.224
   Google Scholar
• Baboo J, Kilbride P, Delahaye M, et al. The impact of varying cooling and thawing rates on the quality of cryopreserved human peripheral blood T cells. Sci Rep. 2019;9(1):3417–3430.
   PubMedGoogle Scholar
• Solomon J, Csontos L, Clarke D, et al. Current perspectives on the use of ancillary materials for the manufacture of cellular therapies. Cytotherapy. 2016;18(1):1–12.
   PubMed Web of Science ®Google Scholar
• Li F, Vijayasankaran N, Shen AY, et al. Cell culture processes for monoclonal antibody production. MAbs. 2010;2(5):466–479.
   PubMed Web of Science ®Google Scholar
• Watanabe K, Ueno M, Kamiya D, et al. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol. 2007;25(6):681–686. .
   PubMed Web of Science ®Google Scholar
• Kaganman I. Throwing a ROCK inhibitor at a problem. Nat Methods. 2007;4(7):544.
   Web of Science ®Google Scholar
• Liao JK, Seto M, Noma K. Rho kinase (ROCK) inhibitors. J Cardiovasc Pharmacol. 2007;50(1):17–24.
   PubMed Web of Science ®Google Scholar
• Wattanapanitch M, Klincumhom N, Potirat P, et al. Dual small-molecule targeting of SMAD signaling stimulates human induced pluripotent stem cells toward neural lineages. PLoS One. 2014;9(9):e106952.
   PubMed Web of Science ®Google Scholar
• Horiguchi I, Urabe Y, Kimura K, et al. Effects of glucose, lactate and basic FGF as limiting factors on the expansion of human induced pluripotent stem cells. J Biosci Bioeng. 2018;125(1):111–115.
   PubMed Web of Science ®Google Scholar
• Hong JK, Nargund S, Lakshmanan M, et al. Comparative phenotypic analysis of CHO clones and culture media for lactate shift. J Biotechnol. 2018;283:97–104.
   PubMed Web of Science ®Google Scholar
• Martano G, Borroni EM, Lopci E, et al. Metabolism of stem and progenitor cells: proper methods to answer specific questions. Front Mol Neurosci. 2019;12:1–17.
   PubMed Web of Science ®Google Scholar
• Singh SJ, Turner W, Glaser DE, et al. Metabolic shift in density-dependent stem cell differentiation. Cell Commun Signal. 2017;15(1):1–12.
   PubMedGoogle Scholar
• Chrysanthopoulos PK, Goudar CT, Klapa MI. Metabolomics for high-resolution monitoring of the cellular physiological state in cell culture engineering. Metab Eng. 2010;12(3):212–222.
   PubMed Web of Science ®Google Scholar
• Heathman TRJ, Glyn VAM, Picken A, et al. Expansion, harvest and cryopreservation of human mesenchymal stem cells in a serum-free microcarrier process. Biotechnol Bioeng. 2015;112(8):1696–1707.
   PubMed Web of Science ®Google Scholar
• Du W, Amarachintha S, Wilson AF, et al. SCO2 mediates oxidative stress-induced glycolysis to oxidative phosphorylation switch in hematopoietic stem cells. Stem Cells. 2016;34(4):960–971.
   PubMed Web of Science ®Google Scholar
• Pimpaneau V, Gianelli F, Trouvin JH, et al. The challenges of potency assay development for cell-based medicinal products in Europe. Regul Rapp. 2015;12:5–10.
   Google Scholar
• Hawkes N. Childhood leukaemia: novartis immunotherapy drug approved after deal with NHS. BMJ. 2018;362:k3799.
   PubMedGoogle Scholar
• Galluzzi L, Martin P. CARs on a highway with roadblocks. Oncoimmunology. 2017;6(12):e1388486.
   PubMed Web of Science ®Google Scholar
• Silverman E. Kymriah: a sign of more difficult decisions to come. Manag Care. 2018;27:1.
   Google Scholar
• Harrison RP, Medcalf N, Rafiq QA. Cell therapy-processing economics: small-scale microfactories as a stepping stone toward large-scale macrofactories. Regen Med. 2018;13(2):159–173.
   PubMed Web of Science ®Google Scholar
• Hampson B Optimizing cost of goods for cell therapy manufacturing [internet]. MINARIS Regenerative Med 2018 [cited 2021 Jan 11]; Available from: https://www.pctcelltherapy.com/pct-pulse/optimizing-cost-of-goods-for-cell-therapy-manufacturing
   Google Scholar
• Albert H The three obstacles stopping cell therapy becoming mainstream [internet]. 2020 [cited 2021 Jan 11]; Available from: https://www.labiotech.eu/in-depth/cell-therapy-obstacles-widespread-use/
   Google Scholar
• Carpenter MK, Rosler E, Rao MS. Characterization and Differentiation of Human Embryonic Stem Cells. Cloning Stem Cells. 2003;5(1):79–88.
   PubMedGoogle Scholar
• Hoffman LM, Carpenter MK. Characterization and culture of human embryonic stem cells. Nat Biotechnol. 2005;23(6):699–708.
   PubMed Web of Science ®Google Scholar
• Lee JB, Lee JE, Park JH, et al. Establishment and maintenance of human embryonic stem cell lines on human feeder cells derived from uterine endometrium under serum-free conditions. Biol Reprod. 2005;72(1):42–49.
   PubMed Web of Science ®Google Scholar
• Denning C, Allegrucci C, Priddle H, et al. Common culture conditions for maintenance and cardiomyocyte differentiation of the human embryonic stem cell lines, BG01 and HUES-7. Int J Dev Biol. 2006;50(1):27–37.
   PubMed Web of Science ®Google Scholar
• Salmikangas P, Menezes-Ferreira M, Reischl I, et al. Manufacturing, characterization and control of cell-based medicinal products: challenging paradigms toward commercial use. Regen Med. 2015;10(1):65–78. .
   PubMed Web of Science ®Google Scholar
• Thomas RJ, Hourd PC, Williams DJ. Application of process quality engineering techniques to improve the understanding of the in vitro processing of stem cells for therapeutic use. J Biotechnol. 2008;136(3–4):148–155.
   PubMed Web of Science ®Google Scholar
• Davie NL, Brindley DA, Culme-seymour EJ, et al. Streamlining cell therapy manufacture. Bioprocess Int. 2012;10:24–49.
   Google Scholar